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M protein, a fibrillar molecule on the surface of the group A streptococcus (1, 
2), confers to the organism the ability to resist attack by human phagocytic cells 
(3),  and thus is considered to be one of the major virulence factors for these 
bacteria.  While type-specific opsonic antibodies to the M  molecule are able to 
neutralize its antiphagocytic effect and thus allow ingestion and killing of the 
streptococcus,  the  presence  in  nature  of  more  than  70  distinct  M  protein 
serotypes has probably been a  major contributing factor in the ability of group 
A streptococci to survive despite immunological pressures. 
M  protein  has  been  isolated  from  streptococci  by  various  methods.  These 
include treatment of the bacteria with acid (4), alkali (5), nonionic detergent (6), 
pepsin (7,  8),  or phage lysin (9).  In addition, M  protein has been isolated as a 
product secreted by streptococcal L-forms and protoplasts (10). Since the secreted 
product  is the largest  M  protein  isolated, and is thus most likely to  be  intact 
native protein, it would be the preparation of choice for further chemical study. 
However,  the  quantities  available  are  too  limited  to  characterize  further.  M 
protein  isolated following treatment,  either with pepsin  at suboptimal pH,  or 
with phage lysin, has proved useful for chemical and structural analysis of the M 
molecules (2, 8, 1 1-15). Although lysin-extracted M molecule appears to be close 
in size to the secreted protein (2,  10),  its relationship to the secreted molecule, 
the  pepsin-extracted  molecule  or  the  native  molecule  on  the  surface  of the 
streptococcus, has not yet been determined. 
To better understand the complete structure of the M molecule we have used 
in vitro recombinant DNA technology. We cloned the structural gene for type 
6  group  A  streptococcal  M  protein  into  Escherichia  coli (E.  coli), where  it  is 
expressed  (16).  Based on  electrophoresis  in  sodium  dodecyl sulfate polyacryl- 
amide gels (SDS PAGE), 1 the M  protein produced in this new host is similar to 
This work was supported in part by National Institutes of Health grant All 1822 (to V. A. Fischetti) 
and American Heart  Association grant  83-1102 (to  B.  N.  Manjula). B.N.M. is an  Established 
Investigator of the American Heart Association. 
Abbreviations used in this paper." CM, carboxymethyl;  ColiM6, Type 6 M protein isolated from E. 
coli; ELISA, enzyme-linked  immunosorbent assay; LysM6, Type 6 M protein isolated from strepto- 
cocci with phage lysin;  MD solution, 10 mM MgCI2  and 100 ttg DNase; PBS, 0.1 M sodium phosphate- 
buffered saline, pH 7.0; PepM6, Type 6 M protein isolated with pepsin at pH 5.8; SDS PAGE, 
sodium dodecyl sulfate polyacrylamide  gel electrophoresis;  TSE buffer, 100 mM Tris, pH 8.0, 20% 
sucrose, 5 mM EDTA; YT, yeast extract tryptone broth. 
J. ExP. MED. © The Rockefeller University Press • 0022-1007/84/04/1083/13 $1.00  1083 
Volume 159  April 1984  1083-1095 1084  STREPTOCOCCAL  M6  PROTEIN  IN  E.  COLI 
that  secreted  from  streptococcal  L-forms and  protoplasts  (10,  16),  but  larger 
than  M  molecules  isolated  from streptococci by pepsin  (8,  11)  or phage  lysin 
treatment  (2).  In  addition,  the  protein  prepared  from  E.  coli  has  the  same 
immunodeterminant(s) as M protein isolated from the streptococcus. 
In  this communication, we describe the localization of the  M6 protein in E. 
coli (ColiM6). We also describe the purification and immunological and biological 
characteristics of the protein prepared from E.  coli.  In addition, we compare its 
amino terminal sequence with purified M  protein isolated from Type 6  strepto- 
cocci by pepsin  extraction  (PepM6)  and  from streptococcal  extracts prepared 
with phage lysin (LysM6). 
Materials and Methods 
Bacterial  Strains  and  Growth  Conditions.  The plasmid  pJRS42.13  was  derived from 
pJRS42 by digestion with EcoRI and religation. It includes a part of the original vector, 
pJB8  (17),  which is a  pBR322-derived replicon, and the structural gene for M6 from 
Streptococcus pyogenes (16). The plasmid is maintained in E. coli K 12 strain C600NR carrying 
lambda ci857, a temperature-inducible prophage. All E. coli strains were grown aerobically 
in yeast extract-tryptone broth (YT) (18) at 30°C in the presence of 20 gg/ml ampicillin. 
Cell Fractionation.  E. coli C600NR(pJRS42.13) was grown in YT broth (50 ml) at 30°C 
to an optical density (OD) of 0.7 at 650 nm.  Cells  were collected by centrifugation at 
7,000 g  and  resuspended  in  2.4  ml  of ice-cold TSE buffer (100  mM  Tris,  pH  8.0, 
containing 20% sucrose and 5 mM EDTA). Lysozyme was added to a final concentration 
of 0.5 mg/mi and, following gentle mixing, the suspension was placed on ice for 20 min. 
For the whole cell control, 0.5 mi of this suspension was then removed and processed as 
described below. MgCI2 was added to the remaining 2.0 ml (50 mM final concentration) 
to stabilize the resultant spheroplasts, and these were then sedimented at 7,000 g for 15 
min.  The supernatant was  filtered through a  0.4-#m  Millipore membrane to give the 
periplasmic fraction, designated SP-1. 
The spheroplasts were washed once in 2.0 ml TSE buffer and sedimented at 7,000 g. 
The supernatant was filtered as in SP-1 above and designated SP-2. 
To lyse the spheroplasts, 0.5 ml of a solution containing 10 mM MgCi2 and 100 #g/ml 
DNase (MD solution) was added to the pellet along with 1.5 ml of water. The spheroplasts 
were then aspirated vigorously several times through a pasteur pipette and frozen (in dry 
ice/ethanol) and thawed twice. The lysate generated by this treatment was centrifuged at 
50,000 rpm for 1 h in a Beckman Type 65 rotor and the supernatant filtered as in SP-1. 
This cytoplasmic fraction was designated SP-3. The insoluble residue in the pellet was 
resuspended in 2.0 ml TSE buffer. 
Lysis of the whole cell control was accomplished by the addition of 15 IA of Triton- 
X100 and  100 ul of MD solution to the 0.5-ml sample (see above) and the mixture was 
frozen and thawed twice and frozen at -70°C. 
A sample of each SP fraction (100 tA) was immediately added to an equal amount of 
SDS loading buffer, boiled for 3  min, and applied to an  SDS  polyacrylamide gel (see 
below). The remainder of each SP fraction was frozen rapidly and maintained in aliquots 
at -70°C. 
Analysis  of M  Protein  in  E.  coli  Culture  Supernatant.  A  50-ml  overnight culture  of 
C600NR(pJRS42.13) in YT medium was cleared by centrifugation at 7,000 g for 10 rain 
and filtered through a  0.22-~m  Millipore membrane (Millipore Corp.,  Bedford, MA). 
The medium was then brought to 65% saturation with ammonium sulfate and allowed to 
remain at 4°C for 18 h. The resulting fine precipitate was collected by centrifugation at 
10,000 g  for 20  min and suspended in  10  ml  50  mM ammonium bicarbonate.  After 
dialysis in this same buffer for 18 h at 4°C, the solution was lyophilized and subjected to 
SDS PAGE.  The presence of M  protein was  determined by immunoblot analysis  (see 
below). 
Immunofluorescence  Analysis.  An indirect immunofluorescence assay was used to deter- FISCHETTI ET  AL.  1085 
mine whether a significant amount of M protein was located on the surface of the E. coli 
strain producing the M protein. E.  coli C600NR carrying plasmid pJRS42.13,  C600NR 
carrying the parent plasmid pJB8,  and  D471,  a  type 6  streptococcal strain,  were each 
grown to late log phase and cells were recovered from a  1-ml aliquot by centrifugation at 
10,000 g for 5 min. The pellet was washed once in cold 1 mM sodium phosphate-buffered 
saline (PBS),  pH 7.0. Antibody (IgG) to type 6 M protein conjugated to fluorescein (19) 
was added, the rrlixture placed on ice for 30 min, and the cells washed three times in cold 
PBS.  The cells were mixed with a p-phenylenediamine-containing mounting solution to 
reduce photo bleaching (20) and examined with a Zeiss fluorescence microscope fitted for 
epifluorescence using a 65x oil immersion lens. 
Large-scale  Isolation  of Crude M  Protein from  E.  coli.  60  l of a  YT culture  of E.  coli 
C600NR(pJRS42.13)  was grown to OD 0.7  at 650  nm.  The cells were harvested in a 
Sharples centrifuge (Sharpies-Stokes, Warminster, PA) and washed once in 100 mM Tris, 
pH 8.0.  The pellet was suspended in  1 1 of ice-cold TSE buffer containing 500  mg of 
lysozyme and incubated on ice for 20 min. MgCI2 was then added to a final concentration 
of 50  mM,  and  the  spheroplasts sedimented  at  7,000 g  for 30  rain.  The supernatant 
(crude periplasm) was immediately aspirated from the pellet and filtered through a 0.45- 
~m Millipore membrane. The filtered supernatant was divided into two equal aliquots, 
one of which was frozen at -70°C and purified separately. The 500-ml supernatant was 
brought  to  65%  saturation  with  ammonium sulfate and  placed at  4°C  for  18  h.  The 
resulting fine precipitate was sedimented at 7,000 g, suspended in 50 ml 5 mM sodium 
acetate, pH 5.5, dialyzed extensively against this buffer and frozen at -70°C until used 
for purification. 
Put,cation of M Protein Isolated from E. coli Periplasm.  All steps were monitored by SDS 
PAGE  and  immunoblot  using  LysM6  monoclonal  antibodies.  The  crude  periplasmic 
extract (after ammonium sulfate fractionation) was applied to a  1.5  x  12 cm column of 
CM cellulose (Whatman) equilibrated in 5 mM sodium acetate, pH 5.5. The column was 
washed with this buffer until the absorption at 280 nm reached baseline. The adsorbed 
M  protein  was  eluted  with  100  mM  sodium  phosphate,  pH  7.0.  The  eluted  protein 
fractions (containing some contaminating proteins) were pooled and applied directly to a 
1.0  x  17  cm column of hydroxylapatite (Bio-Rad Laboratories, Richmond, CA) equili- 
brated  in  25  mM  sodium phosphate, pH  7.0.  The column was washed with  200  mM 
sodium phosphate, pH 7.0, until there was no detectable absorbance at 280 nm. The M 
protein was then eluted with 400 mM sodium phosphate, pH 7.0. Appropriate fractions 
were pooled, dialyzed extensively against 50 mM ammonium bicarbonate, and stored in 
the lyophilized state. 
Alkaline Phosphatase Assay.  The presence of alkaline phosphatase in E. coli cell fractions 
was detected essentially by the method of Brickman and Beckwith (21).  Cell fractions SP- 
1 to SP-3, insoluble residue, and the whole cell lysate were diluted  1:10 in 1.0 M veronal 
acetate buffer, pH 8.6.  A  4% solution of sodium p-nitrophenyl phosphate (Sigma) (0.1 
ml) was added to each tube and incubated at 37°C for 2 h. The released p-nitrophenol 
color was determined by the absorbance at 420 nm. The concentration of the released p- 
nitrophenol was determined by comparing the absorbance to that of a standard curve of 
p-nitrophenol (Sigma) diluted in 1 M veronal buffer, pH 8.6. 
SDS PAGE and Immunoblot Analysis.  Proteins were separated on  12% SDS-polyacryl- 
amide gel slabs by the method of Laemmli (22).  Molecular weight standards were run 
concurrently in parallel wells. Gels were either stained with Coomassie Brilliant Blue R in 
10% acetic acid-25% n-propanoi and destained with 10% acetic acid-25% n-propanoi, or 
electrophoretically transferred onto nitrocellulose (Schleicher & Schuell, Inc., Keene, NH) 
(23). 
Specific proteins bound to the nitrocellulose membrane were visualized immunologi- 
cally by the method of Blake et al. (24). After transfer to nitrocellulose, the membrane 
fraction  was  reacted  either  with  polyclonal  or  monoclonai  antibodies  made  to  lysin- 
extracted  M6  protein.  The  bound  antibody  was  detected  with  alkaline  phosphatase- 
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The  bands  were  visualized  with  5-bromo-4-chloro-3-indolyl phosphate  (Sigma)  as  the 
alkaline phosphatase substrate and nitroblue tetrazolium (Sigma) as the chromophore. 
Bactericidal Assay.  The indirect bactericidal assay was carried out as described originally 
by Lancefield (25) with modifications described by Fischetti et al. (6). 
Absorption of Opsonic Antibodies.  Purified M6 protein extracted from E. coli was lyophi- 
lized in two 300-#g aliquots. Rabbit type 6 opsonic antiserum prepared against LysM6 
protein (0.5 ml) was added to one, and a similar amount of human serum opsonic for type 
6 streptococci was added to the other dried protein sample. The tubes were incubated at 
37°C for 1 h and then at 4°C overnight. The precipitate was removed by centrifugation 
at 20,000 g for 15 min and the supernatant was used in a bactericidal assay with type 6 
streptococci. 
Rabbit Immunization.  Antisera to the purified ColiM6 protein was prepared in New 
Zealand white rabbits. The primary immunization consisted of 100 #g of ColiM6 protein 
emulsified with complete Freund's adjuvant and given intracutaneously at multiple sites. 
The animals were boosted after 4  wk  with the  same  dose of the  ColiM6 protein  in 
incomplete Freund's adjuvant. Animals were bled 10 d later. 
Amino Acid  Analysis.  Quantitative amino acid analysis  was performed on five nmol 
samples of lyophilized ColiM6, as well as LysM6 (reference 2, manuscript in preparation). 
Samples were hydrolyzed with 6 N HCI at 110oc for 18 h in evacuated sealed tubes (6). 
Amino  Terminal Sequence Analysis.  Automated Edman degradations were performed 
with a  Beckman Sequencer (updated 890B;  Beckman  Instruments,  Fullerton, CA)  as 
previously described (8) on 30-50 nmol of protein. 
Protein Determination.  Protein concentration was determined by the method of Lowry 
et al. (26) using bovine serum albumin as a standard. 
Enzyme-linked Immunosorbent Assay (ELISA).  The ELISA assay was based on the method 
of Engvali and Perlman (27) with modifications described by Fischetti (28). 
Preparation of Monoclonal Antibodies.  BALB/C mice were immunized intraperitoneally 
with 200 #g of purified LysM6 protein in complete Freund's adjuvant. After 4 wk, mice 
were bled and tested for antibodies to LysM6 protein by ELISA assay. Mice with high 
titers of antibodies were given a  second dose of antigen (200  #g) intraperitoneally in 
distilled water. Mouse spleens were excised 3-3.5 d after the booster dose and fusion of 
spleen cells to P3-NS1/1Ag4-1  (NS-1) myeloma cells was performed essentially by the 
method of K6hler and Milstein (29) with modifications by Gaifre et al. (30). Hybridomas 
cloned by limiting dilution were grown as ascitic tumors in pristane-primed mice (31) and 
the ascitic fluid collected and precipitated with 50% ammonium sulfate. Purification of 
the immunoglobulin was completed by chromatography on protein A Sepharose (32). 
Results 
Localization of the M  Molecule in E.  coli.  E.  coli C600NR(pJRS42.13)  was con- 
verted  to  spheroplasts  and  the periplasmic  proteins  were  separated  from  the 
spheroplasts by centrifugation (33). The spheroplasts were osmotically and phys- 
ically lysed, and  the  membranes  along with  other  macromolecular structures 
were separated from the soluble cytoplasmic proteins by ultracentrifugation. To 
separate  the  proteins  present  in  each  fraction,  equivalent  amounts  of  each 
fraction (based on the original cell concentration) were used for SDS PAGE. 
Virtually all of the protein reactive with monoclonal antibodies to the LysM6 
protein was in the periplasmic fraction of the E.  coli cells (Fig.  1 b, SP-1) with a 
trace reaction in the cytoplasmic fraction (SP-3).  The immunoblot assay of the 
periplasmic fraction detected only three immunoreactive bands on the nitrocel- 
lulose that stained with varying intensity, the center band appearing less concen- 
trated. The apparent molecular weights of the bands were 55,000,  57,000, and 
59,000.  A  faint  immunoreactive  band,  which  appears  to  be  a  degradation 
product, was occasionally seen within this fraction at ~35,000 tool wt. An extra FISCHETTI ET  AL.  1087 
FIGURE  1.  (a) Coomassie Blue-stained  SDS polyacrylamide gel of E.  coli fractions. E.  coli 
strain C600NR(pJRS42.13) was converted to spheroplasts and separated into periplasmic (SP- 
1), wash (SP-2), and cytoplasmic (SP-3) fractions. Equivalent amounts of each fraction, based 
on the cell concentration, were applied to a 12% SDS gel along with purified ColiM6 protein. 
The SDS gel was stained with Coomassie Blue and destained as described in Materials and 
Methods. Molecular weight standard  proteins (MW) are phosphorylase b  (94,000), bovine 
serum  albumin (67,000), ovaibumin (43,000), carbonic anhydrase  (30,000), and  soybean 
trypsin inhibitor (20,000). (b) Immunoblot analysis of E. coli fractions. Same protocol as in a, 
except the separated proteins were electrophoretically transferred to nitrocellulose and proc- 
essed for immunoreactive bands with monoclonal antibody prepared against LysM6 protein 
as described in Materials and Methods. 
weakly reactive band  was also observed in  the cytoplasmic fraction (SP-3) with 
an  apparent  mol  wt  of 63,000.  A  stained  gel  of the  same  fractions  (Fig.  1 a) 
revealed  that  the  three  immunoreactive  bands  found  in  the  periplasm  were 
among the prominently staining  proteins in  this  fraction (SP-1).  Since alkaline 
phosphatase is located solely in the E.  coli periplasm (33), its activity was used as 
a  marker to determine the degree of periplasmic contamination in the nonperi- 
plasmic fractions.  Nearly all of the alkaline phosphatase activity was  located in 
the periplasmic fraction, with none seen in the wash (SP-2) or cytoplasm (SP-3) 
(Table I); the remaining activity was located in the insoluble residue (containing 
membranes,  unlysed cells,  and  macromolecules).  In  some  experiments a  small 
amount  of alkaline  phosphatase  activity was  found  in  the  SP-2  wash  fraction 
(< 10%). When this occurred, the immunoblot showed a small amount of immu- 
noreactive protein in this fraction as well. 
When the culture supernatant from E.  coli C600NR(pJRS42.13)  was concen- 
trated  100-fold and examined by immunoblot assay with type 6  antiserum,  no 
reactivity was observed. Furthermore, no immunofluorescence due to M6 protein 1088  ST~,.EPTOCOCCAL M6  PROTEIN  IN  E.  COL1 
TABLE  I 
Presence of Alkaline Phosphatase Activity in E. coli 
C600NR(pJRS4 2.13) Cell Fractions 
Cell fractions  Percent* 
SP-1 (periplasmic)  84 
SP-2 (wash)  0 
SP-3 (cytoplasmic)  0 
Insoluble residue  16 
* Expressed as percentage of total activity. Average of two independent 
determinations. 
FIGURE 2.  SDS PAGE  and immunoblot analysis of purified ColiM6 protein. Two samples of 
purified ColiM6 protein were separated on a 12% SDS polyacrylamide  gel in alternate tracks. 
The gel was cut between the tracks and each processed separately. The proteins in one track 
(right) were electrophoretically transferred  to nitrocellulose and  reacted  with monoclonal 
antibodies to LysM6 protein. The bound antibody was visualized  as described in the Materials 
and Methods. The second track (left) was stained with Coomassie Brilliant Blue and destained. 
was  detectable  on  the  surface  of C600NR(pJRS42.13),  although  the  type  6 
streptococcal strain D471  exhibited bright fluorescence (data not shown). 
Purification  of  the  M  Protein  Produced  by  E.  coli.  Since  comparison  of  the 
immunoblot with the stained gel revealed that the M6 protein was concentrated 
within  the periplasmic  space and  was  one of the  major proteins within  it,  this 
fraction served as  the  starting  material  for further purification  of the  ColiM6 
molecule. Chromatographic purification of ColiM6 on columns of CM-cellulose 
and hydroxylapatite (see Materials and Methods) resulted in a  preparation  that 
contained three protein bands.  These bands could be visualized either by Coo- 
massie  Blue staining of the SDS polyacrylamide gel or by immunobiot analysis 
with monoclonai (Fig. 2) as well as polyclonal antibodies (data not shown) to the 
LysM6 protein. The mobilities of the protein bands in SDS PAGE of the purified 
preparation were identical to those of the M  protein present in crude lysates of 
E.  coli (see Fig.  1 a, ColiM6). In contrast to the crude preparation, the lowest of 
the three bands  in  the purified preparation  was  more concentrated in  relation FISCHETTI  ET  AL.  1089 
to the other two. The total yield of purified ColiM6 protein from 60 1 of culture 
was 52 mg. 
Amino  Acid  Analysis.  The  amino  acid  composition  of the  purified  ColiM6 
protein  is  compared  to  that  of the  LysM6  in  Table  II.  Except  for  the  slight 
differences in the leucine and threonine content, the amino acid compositions of 
the two molecules are essentially identical. 
Sequence  Analysis.  The  amino  terminal  sequence  of  the  ColiM6  protein 
through  residue  34  is  presented  in  Fig.  3.  Despite  the  three  protein  bands 
observed in SDS gels both by Coomassie Blue staining and immunoblot analysis, 
TABLE  II 
Comparison of the Amino Acid Composition of LYSM6 and Colim6 
Proteins 
Amino acid 
Residues/1 O0 
Lysm6*  Colim6* 
GLU  20.3  20.1 
LYS  17.4  16.9 
ASP  13.9  14.0 
LEU  12.3  11.3 
ALA  10.4  9.9 
THR  6.7  7.6 
GLY  3.4  3.9 
ILE  3.0  2.8 
ARG  4.2  3.9 
SER  3.4  3.2 
VAL  3.0  3.3 
PRO  0.8  1.4 
MET  0.3  0.6 
TYR  0.2  0.2 
PHE  0.1  0.3 
HIS  --~  -- 
CYS  --  -- 
TRP  --  -- 
* Average of two determinations. 
* Average of three determinations 
No detectable amounts. 
from two different lots. 
COLIM6 
1  10  ?0 
Arg-Val-Fne-ProlArg-GJy-Thr-Vol-Glu~Asn-Pro~Asp-Lys-AJo-Arg-Glu-Leu-Leu-Asn-Lys  - 
30  34 
"ryr-Asp-Vo f-G Ju-Am-Ser-Met -Leu-GIn  -AI o-A~-Asn-AsP-Lys 
LYSM6 
1  tO  20 
VO r-Phe  -Pro-Arg- Gly-Thr - VaI-GI u  -Asn-Pro-ASp-Lys-Ala-Arg-Glu  -Leu~Leu- A~-Lys- 
30  36 
Tyr -Asp-VaI-Glu-Am-Ser  -Met-Leu- GIn-Ala-As~-Asn-Asp-Lys-  Leu-Thr 
PEPM6 
l  I0  20 
Arg-VoI-Phe-Pro-Mg-Gly-Thr-Val-Gfu-Asn-Pro-Asp-Lys-Ala-Arg-Glu-Leu-  Leu-Asn-Lys- 
3o  35 
Tyr -Asp-Vol- G  Ju -Ash -Ser  - Met-Leu-Gtn-A la -Asn-Asn -Asp-Lys-Leu 
FIGUR~ 3.  Comparison of the amino terminal  sequence of three preparations of M6 protein. 
The amino terminal  sequence  of the ColiM6 protein is compared with the amino terminal 
region of purified M6 protein isolated from type 6 streptococci  with phage lysin (LysM6) or 
pepsin (PepM6).  The residue numbers in the LysM6 sequence are offset by 1 to correspond 
with the numbering of the ColiM6 and PepM6 sequences. 1090  STREPTOCOCCAL  M6  PROTEIN  IN  E.  COLI 
only a  single residue was observed at each degradation step. The yield of the 
amino  terminal  residue  at  each  step  was  that  expected  from  the  amount  of 
protein applied to the sequencer. The amino terminal sequence of the ColiM6 
molecule is identical to that of the M6  protein isolated from the streptococci 
either by limited pepsin digestion (PepM6) or by solubilization of the cell wall by 
phage lysin (LysM6) (Fig. 3), except for the amino terminal residue in the LysM6 
molecule. 
Biological Properties of the ColiM6 Molecule.  As an indication of the immuno- 
genicity of the purified ColiM6 protein, its ability to induce opsonic antibodies 
in rabbits was examined. The indirect bactericidal test revealed that after two 
immunizations, antibodies opsonic for type 6 streptococci are produced (Table 
III). The ColiM6 protein was also able to effectively remove opsonic antibodies 
from both human and rabbit opsonic serum (Table IV). 
TABLE  III 
Production of Rabbit Type 60psonic Antibodies with Colim6 
Protein* 
No. of colonies 
Inoculum  32 
Control*  2,680 
Preimmune serum  2,144 
Immune serum  3 
* The indirect bactericidal assay was performed with whole heparinized 
(10  U/ml)  human blood (400  #1) as  a  source of phagocytic  cells.  A 
dilution of virulent type 6 streptococci (100 #1) was added in the presence 
or absence of test serum (100 #l). The tubes were sealed and rotated for 
3  h  at  37°C  and  the  surviving organisms determined by pour  plate 
method. 
* The number of colony-forming units after 3 h of rotation with strepto- 
cocci and blood alone. 
TABLE  IV 
Removal of Opsonic Antibodies  from Rabbit and Human Serum with 
Colim6 Proteins* 
No. of colonies* 
Rabbit 
Inoculum  20 
Control  s  790 
Rabbit serum: 
Unabsorbed  8 
Absorbed with Colim6  620 
Human 
Inoculum  7 
Control  s  1,040 
Human serum: 
Unabsorbed  0 
Absorbed with Colim6  650 
* The indirect bactericidal assay is described in Table III. 
* Representative results from several experiments. 
s The  number of colony-forming units after  3  h  of rotation with only 
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Discussion 
Nearly  all  of  the  M6  protein  synthesized  by  E.  coli  carrying  the  plasmid 
pJRS42.13 is accumulated within the periplasmic space. No immunoreactive M 
protein was found either on the surface of the E.  coli (by immunofluorescence) 
or in the culture medium that had been concentrated 100-fold. 
Because  the  ColiM6  protein  was  localized  in  the periplasm,  which did  not 
contain many other major proteins, purification of the M6 molecule was simpli- 
fied. The final yield of purified ColiM6 protein was ~ 1 mg per liter of culture. 
It is difficult, however, to correlate this quantity with the amount present on the 
streptococcal  surface  because  of the  problems  encountered  in  quantitatively 
removing M protein from the streptococcal cell wall. 
When  freshly extracted  from the E.  coli periplasmic space,  immunoreactive 
M6 protein consisted of three closely spaced bands usually appearing with equal 
intensity on  SDS  polyacrylamide gels and immunobiot. In some preparations, 
however, the center band appeared more concentrated, while in others the upper 
band predominated. A small amount of immunoreactive protein, similar to that 
seen in the periplasm, was sometimes observed in the cytoplasm. In addition, a 
small quantity of a  larger molecular weight immunoreactive protein, not found 
in  the  periplasm,  was  occasionally  present  within  the  cytoplasmic  fraction. 
Whether or not this larger molecular species is a precursor form of the M protein 
molecules found in the periplasm is currently being investigated. 
Since the purified ColiM6 protein was identical in mobility on SDS polyacryl- 
amide gels to that in freshly lysed E.  coli, it seems likely that little or no major 
degradation occurred during the purification process (see Fig. 1). It was observed, 
however, that in the purified ColiM6 preparation, the lowest of the three bands 
was more concentrated than the other two, while this was not the pattern in the 
freshly prepared  crude periplasm.  Whether  the increase  in concentration ob- 
served  in  the  lower  band  is  the  result  of partial  degradation  of  the  upper 
molecules, charge alterations during purification, or the preferential purification 
of the lower molecular weight species is not clear at present. The last hypothesis 
is least likely, since reactive proteins comparable to the two upper bands were 
not observed by immunoblot analysis of the other fractions during purification. 
Multiple  closely spaced  bands  of M  protein  have  previously been  observed 
when M6  was prepared  from streptococci with phage lysin (9,  16),  while the 
preparation of M  protein obtained by secretion from streptococcal protoplasts 
or L-forms is a  single band on SDS  PAGE (10).  Because of the differences in 
appearance on gels of M protein prepared from streptococci by different tech- 
niques, we cannot tell whether the banding observed in the ColiM6 preparation 
is  due  to  modifications peculiar  to  the  E.  coli.  Although  the  amino  terminal 
region  of  the  ColiM6  appears  homogeneous,  the  occurrence  of  proteolytic 
cleavage at the carboxy-terminal region of the larger two proteins resulting in 
an increase of the lower molecular weight species cannot presently be ruled out. 
Muscle  tropomyosin,  a  fibrous  molecule  that  is  similar  in  structure  to  M 
proteins  (2,  12),  displays  anomalous  behavior  on  SDS  gels.  Tropomyosin  is 
composed of two alpha-helical polypeptide chains, termed alpha and beta, each 
of which are  284 residues long and present at a  3.8:1  alpha/beta  ratio in the 
rabbit skeletal molecule (34). The beta chain differs from the alpha in 39 residues, 1092  STREPTOCOCCAL  M6  PROTEIN  IN  E.  COL1 
most of which are conservative substitutions (35). Despite their identical size, the 
alpha  chain  may be  separated  from the beta  chain on  SDS  gels.  It  has been 
suggested  that  the  observed  separation  is  based  on  the  difference between 
phosphorylated and unphosphorylated species of tropomyosin (36), along with 
the differences in  primary structure (37).  In  preliminary studies,  we did  not 
observe any changes in migration on SDS gels of the three ColiM6 proteins after 
phosphatase treatment. Thus, further studies will be required along with DNA 
sequence analysis of the M  protein gene to clarify the nature of the multiple 
banding pattern. 
M protein on the surface of the streptococcus is composed of dimers arranged 
as fibrillar coiled-coil molecules (2, 12). Extraction of the M protein with pepsin 
at pH 5.8 cleaves the molecule approximately at its center, leaving a portion of 
the M  protein still  attached to the cell surface (2).  With the exception of the 
amino terminal residue of the LysM6 molecule, the amino terminal sequences 
of the ColiM6,  LysM6, and PepM6 molecules are identical. This information, 
along with  the  knowledge that  the  PepM6  molecule is  a  fragment of the  M 
protein derived from the whole cell (2),  is evidence that the amino terminus of 
the M protein is distal to the streptococcal cell wall, and the carboxy-terminal 
region is involved in its attachment to the cell, as was previously suggested (2), 
The fact that the LysM6 protein lacks the amino terminal residue present in 
the other two molecules suggests that an enzyme with the ability to cleave the 
amino terminal arginine may be present during the isolation of this molecule. 
Streptococcal proteinase is a papain-like sulfhydryl-dependent enzyme produced 
by most group A  streptococci. This enzyme has the appropriate  specificity to 
cleave the amino terminal arginine (38) under conditions used for the solubili- 
zation of the group A streptococcal cell wall with phage lysin (39). 
The similarity in molecular size (16) and near identity of amino acid composi- 
tion  between  the  LysM6  and  ColiM6  molecules indicates  that  the  molecule 
synthesized in E.  coli is likely to be the same as the complete M6 protein, as it 
exists on the streptococcus. 
The finding that the amino terminal sequence of the ColiM6 molecule that is 
exported into the E. coli periplasmic space is the same as the M6 molecule isolated 
from the streptococcus, indicates that the process necessary to remove the amino 
terminal signal sequence during the export process has the same specificity in 
both  organisms.  No  immunoreactive  M  protein  could  be  isolated  from  the 
extracellular growth media or observed on the E. coli surface. This suggests that 
the newly synthesized M  molecule does not have the  structures necessary to 
penetrate the E. coli outer membrane. 
We  have  previously shown  by  immunodiffusion experiments (16)  that  the 
ColiM6 molecule contains antigenic determinants similar to those present on M6 
protein isolated from the streptococcus. Further analysis here revealed that the 
ColiM6 protein is also able to stimulate the production of opsonic antibodies to 
type 6  streptococci, as well as to remove type 6  opsonic antibodies from both 
rabbit and human serum. This indicates that the M protein molecule synthesized 
in E.  coli and transported to the periplasm has the same immunologically func- 
tional determinants as those found on M molecules isolated from the streptococ- 
cus (6-8). These results also suggest that the coiled-coil conformation of the M FISCHETTI ET  AL.  1093 
molecule (2) may be conserved in the E. coli preparation,  however, physicochem- 
ical studies will be necessary to confirm this. 
Summary 
Type 6 streptococcal M protein produced by E. coli bearing plasmid pJRS42.13 
(ColiM6) accumulates in the periplasmic space of this new host. No immunoreac- 
tive M protein was found either on the surface of the organism or in the culture 
medium.  The  ColiM6  protein  was purified  from  the  periplasm  and  the  final 
preparation  consisted  of three  protein  bands  of apparent  molecular  weight 
55,000,  57,000, and  59,000.  These three bands were identical in migration  in 
SDS PAGE to that of the M protein present in freshly prepared crude periplasm. 
The amino acid composition of the ColiM6 protein was nearly identical to that 
of M protein isolated from streptococci with phage lysin (LysM6). Furthermore, 
except for the amino terminal residue of the LysM6 molecule, the amino terminal 
sequence of the ColiM6 molecule was identical to those of both LysM6 and  M 
protein  released  from  the  streptococcus by limited  peptic  digestion  (PepM6). 
These results reveal that  the molecule produced in the E.  coli and transported 
into the periplasm may be the complete M protein as it exists on the streptococcus. 
The results also indicate that  the systems that process M protein  for transport 
through the cytoplasmic membrane are similar in the streptococcus and E. coli. 
The purified ColiM6 protein was able to remove opsonic antibodies from both 
human  and  rabbit  serum,  as  well  as  to  stimulate  the  production  of opsonic 
antibodies in rabbits, indicating that the immunodeterminants  on this molecule 
are the same as those found on streptococcal-derived M molecules. 
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